Immunic, Inc.
IMUX
$1.18
-$0.03-2.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -97.17M | -103.05M | -101.84M | -96.40M | -100.51M |
| Total Depreciation and Amortization | 168.00K | 161.00K | 163.00K | 151.00K | 134.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.36M | 9.70M | 8.01M | 7.62M | 15.28M |
| Change in Net Operating Assets | 1.84M | 3.70M | 3.52M | 6.05M | 330.00K |
| Cash from Operations | -85.81M | -89.49M | -90.14M | -82.57M | -84.77M |
| Capital Expenditure | -161.00K | -153.00K | -136.00K | -280.00K | -264.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -161.00K | -153.00K | -136.00K | -280.00K | -264.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 74.27M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 65.58M | 65.60M | 65.60M | 83.00K | 274.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -6.00K | -6.00K | -6.00K | -6.00K |
| Cash from Financing | 65.58M | 65.60M | 65.60M | 77.00K | 74.54M |
| Foreign Exchange rate Adjustments | 205.00K | 107.00K | 296.00K | -232.00K | -517.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.19M | -23.94M | -24.39M | -83.01M | -11.01M |